ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,363.36
1.81%
US Tech 100
18,164.80
1.78%
다우존스 지수
40,212.71
1.56%
Bitcoin
84,777.91
1.64%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Mineralys Therapeutics Inc (MLYS) 시세

Mineralys Therapeutics Inc

Mineralys Therapeutics Inc (MLYS)

NASDAQ
13.40
1.21
(9.93%)
마감 13 4월 5:00AM
15분 지연
13.39
-0.01
(-0.07%)
시간외 거래: 8:38AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
13.39
매수가
13.20
매도가
14.88
거래량
835,481
11.77 일간 변동폭 13.53
8.241 52주 범위 18.38
market_cap
667.299M
전일 종가
12.19
개장가
12.06
최근 거래 시간
7
@
13.21
마지막 거래 시간
재정 규모
US$ 10,618,258
VWAP
12.7092
평균 볼륨(3m)
1,132,464
발행 주식
49,835,637
배당수익률
-
주가수익률
-3.76
주당순이익(EPS)
-3.57
매출
-
순이익
-177.81M

Mineralys Therapeutics Inc 정보

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in... Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.mineralystx.com
본부
Wilmington, Delaware, USA
설립됨
-
Mineralys Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker MLYS. The last closing price for Mineralys Therapeutics was US$12.19. Over the last year, Mineralys Therapeutics shares have traded in a share price range of US$ 8.241 to US$ 18.38.

Mineralys Therapeutics currently has 49,835,637 shares in issue. The market capitalisation of Mineralys Therapeutics is US$607.50 million. Mineralys Therapeutics has a price to earnings ratio (PE ratio) of -3.76.

MLYS 최신 뉴스

추가 뉴스

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
09 4월 2025
MLYS (9.93%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
09 4월 2025
MLYS (9.93%)

Form 8-K - Current report
Edgar (US Regulatory)
31 3월 2025
MLYS (9.93%)

Form 8-K - Current report
Edgar (US Regulatory)
13 3월 2025
MLYS (9.93%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
13 3월 2025
MLYS (9.93%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.110.82831325301213.2813.4910.44157285712.30400721CS
4-0.48-3.4607065609213.8718.3810.44145039414.51193072CS
123.8139.77035490619.5818.388.241113246413.68219259CS
260.020.14958863126413.3718.388.24163103813.49930439CS
520.443.3976833976812.9518.388.24139903713.26582313CS
156-7.71-36.540284360221.121.985.8528518613.20596696CS
260-7.71-36.540284360221.121.985.8528518613.20596696CS

MLYS - Frequently Asked Questions (FAQ)

What is the current Mineralys Therapeutics share price?
The current share price of Mineralys Therapeutics is US$ 13.39
How many Mineralys Therapeutics shares are in issue?
Mineralys Therapeutics has 49,835,637 shares in issue
What is the market cap of Mineralys Therapeutics?
The market capitalisation of Mineralys Therapeutics is USD 607.5M
What is the 1 year trading range for Mineralys Therapeutics share price?
Mineralys Therapeutics has traded in the range of US$ 8.241 to US$ 18.38 during the past year
What is the PE ratio of Mineralys Therapeutics?
The price to earnings ratio of Mineralys Therapeutics is -3.76
What is the reporting currency for Mineralys Therapeutics?
Mineralys Therapeutics reports financial results in USD
What is the latest annual profit for Mineralys Therapeutics?
The latest annual profit of Mineralys Therapeutics is USD -177.81M
What is the registered address of Mineralys Therapeutics?
The registered address for Mineralys Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Mineralys Therapeutics website address?
The website address for Mineralys Therapeutics is www.mineralystx.com
Which industry sector does Mineralys Therapeutics operate in?
Mineralys Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
85.68M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
29.09M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.75M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
48.09M
MBMasterBeef Group
US$ 3.30
(-90.95%)
2.46M
ATHRAether Holdings Inc
US$ 5.5102
(-87.75%)
581.85k
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.19k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.95M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.09M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.04B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
653.46M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
640.47M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
303.97M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
261.75M

토론

전체 피드 보기
Lime Time Lime Time 1 분 전
Did anybody notice that Easter is on 420 this year
shell3 shell3 2 분 전
Outstanding: 115,244,104 for April 5, 2025

Monthly 5th Report

https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_April_5_2025.pdf?28tTO0piri4qXL9OunqBfnnd0x_vEhDM

Someone took their 100,000 $BLO Options @ $0.25 which would be $0.18 $BLOZF
BLO BLOZF
Stks_Not_Toys Stks_Not_Toys 3 분 전
Yup, we shoulda sold. Greedy us.
GRRR
waterchaser waterchaser 3 분 전
I can’t wait to see his response.
Oh wait… never mind, there won’t be one.
HMBL is garbage and most pumpers know that.
HMBL
pcguy pcguy 4 분 전
I updated my post. Neither of the Wheatlands look like anyone in the video.
AVXL
hotmeat hotmeat 4 분 전
FDA approval is basically a "Golden Ticket" into the Cancer treatment markets of virtually every country in the world simply because, whether actually deserved or not , their stamp of approval is universally accepted as being ""credible"".

No offence to the Indian medical establishm
RDGL
Tommy321 Tommy321 4 분 전
When have this an end? Where is the judge who tells Samsung it’s finished, there is no possibility for a delay anymore! The game is over! Where is the judge? Who has the eggs? Unbelievable we won three times the BOC and Damsung still has the chance vocation?!!! Unbelievable!!!
NLST
ChannelTrader ChannelTrader 5 분 전
Thank you.
XRPUSD
Lime Time Lime Time 5 분 전
I disagree. It's been low quality since April 2nd.
jimr1717 jimr1717 6 분 전
Another “ Unwinding”. That’s all this scam does. They even include Unwinding the wealth of anyone foolish enough to buy shares.
HMBL
XMaster2023 XMaster2023 6 분 전
Running my own post through Gemini
The information you've provided touches on some real aspects of cancer treatment and the potential effects of immunotherapies like DCVax-L. Let's break down each part:
* Tumors shrink with radiation and chemotherapy: This is generally true. Radiatio
NWBO
tdbowieknife tdbowieknife 6 분 전
Some reading material for ya...

https://drive.google.com/file/d/1nYtWEhrTuwtWbRTLjHodbovvqugYPXwE/view

.


Watch your wallet


Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/
HMBL
Almosthere Almosthere 7 분 전
At December 31, 2024, we had cash and cash equivalents of $7.9 million.

Approximately $42.5 million remains available on the ATM equity offering program at December 31, 2024.
LQMT
Wayne R Wayne R 7 분 전
It could be that you need to see an optician
FOFreddie FOFreddie 7 분 전
2021 Letter Agreement "Litigation End Date "

“Litigation End Date” means the date on which all litigation pending as of January 14, 2021, against Purchaser, Seller, or the United States or any of its agencies or officers arising out of or in connection with the placement of Seller int
FNMA
timez1000 timez1000 7 분 전
Perfect response from Emil.  He knows what the F he is doing, crossing all t's and dotting all i's
"I did not purchase this company to do nothing"
Nuff said.
As well, Marshak and Stark are not here to do nothing either.
No worries, it's coming, and it's going to be huge.
TWOH
Remember Tomorrow Remember Tomorrow 7 분 전
You’ll get sick of the charts eventually. As far as insight goes, just posting charts that are often contradictory the the ones posted the day before and leaving others to interpret them doesn’t seem very insightful to me.

Remember Tomorrow
XRPUSD
Jack_Herer Jack_Herer 8 분 전
No pennies remaining to pay mascarpone, small time tuna, or even continued rental of the sheik costume.
They're not even bothering to update their crappy website (still showing pink current).

https://investorshub.advfn.com/uimage/uploads/2020/12/17/szcswclownpockets.jpg
HIRU
ajaxxx_99 ajaxxx_99 8 분 전
Please do not encourage anyone to invest 10K into this company. That is irresponsible. For shame.
ERHE
georgejjl georgejjl 8 분 전
pcguy,

Ern is short for Ernest. That name is or was quite common as is or was the name Margaret.

We have been discussing Ern Heaven, who is still alive and taking blarcamesine each and every day to treat Alzheimer's.

The people you posted about are two to
AVXL
ajaxxx_99 ajaxxx_99 8 분 전
Please do not encourage anyone to invest 10K into this company. That is irresponsible. For shame.
ERHE
elks elks 9 분 전
Hear that.
TWOH
ajaxxx_99 ajaxxx_99 9 분 전
I know this is not new. But for crying out loud, this company was shady as of 2006. There was no outcome other than PN and his cronies getting kickbacks, and payoffs. I have posted excerpts. You can read the whole mess https://www.sec.gov/Archives/edgar/data/799235/000114036107002973/form10-q.htm
ERHE
FrostyEmpire44 FrostyEmpire44 10 분 전
FNMA Valuation today based on Annual report for 2024

Simple Book Value = Equity divided by common shares outstanding. $94,657M or for those who want simpler $94.7B dollars divided by $1.16B shares outstanding = $81 dollars and change per share. For comparisons JP Morgan chases trade
JPM

최근 히스토리

NASDAQ
MLYS
Mineralys Therapeutics
COIN
SANDUSD
Sandbox
COIN
NMRUSD
Numeraire
NASDAQ
NYMX
Nymox Pharmaceutical
COIN
SCAMUSD
SCAM
BIBX
BOTETH
Bodhi [Qtum]
AQSE
ROCK.GB
Rockfire Resources
ASX
PKO
Peako
NASDAQI
LDSF
First Trust Low Duration...
COIN
COVAUSD
Covalent Token
ASX
OBL
Omni Bridgeway
CSE
CHV
Canada House Wellness
TG
XM29
Xtrackers
EU
TLT
The London Tunnels
TG
AWY0
Percheron Therapeutics
COIN
EXRTUSD
EXRT
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지